发明申请
US20050197301A1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease
失效
3,4-（环戊基） - 脯氨酸化合物作为丙型肝炎病毒NS3丝氨酸蛋白酶的抑制剂
- 专利标题： 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine protease
- 专利标题（中）： 3,4-（环戊基） - 脯氨酸化合物作为丙型肝炎病毒NS3丝氨酸蛋白酶的抑制剂
-
申请号： US11064757申请日： 2005-02-24
-
公开(公告)号： US20050197301A1公开(公告)日： 2005-09-08
- 发明人: F. Njoroge , Srikanth Venkatraman , Ashok Arasappan , Francisco Velazquez , Viyyoor Girijavallabhan
- 申请人： F. Njoroge , Srikanth Venkatraman , Ashok Arasappan , Francisco Velazquez , Viyyoor Girijavallabhan
- 专利权人： SCHERING CORPORATION
- 当前专利权人： SCHERING CORPORATION
- 主分类号： A61K38/04
- IPC分类号： A61K38/04 ; C07D209/52 ; C07K5/02 ; C07K5/04 ; C07K5/08
摘要：
The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.
公开/授权文献
信息查询
IPC分类:
